SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-028388
Filing Date
2023-06-05
Accepted
2023-06-05 16:54:06
Documents
10

Document Format Files

Seq Description Document Type Size
1 DFAN14A ny20009418x1_dfan14a.htm DFAN14A 26553
2 EXHIBIT 1 ny20009418x1_ex1.htm EX-1 4365
3 ny20009418x1_ex1image-1.jpg GRAPHIC 1014095
4 ny20009418x1_ex1image-4.jpg GRAPHIC 80666
5 ny20009418x1_ex1image-5.jpg GRAPHIC 88577
6 ny20009418x1_ex1image-6.jpg GRAPHIC 82915
7 ny20009418x1_ex1image-7.jpg GRAPHIC 120279
8 ny20009418x1_ex1image-8.jpg GRAPHIC 400921
9 ny20009418x1_ex1image-9.jpg GRAPHIC 539887
10 ny20009418x1_ex1image-10.jpg GRAPHIC 147256
  Complete submission text file 0001140361-23-028388.txt   3424933
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Subject) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-35299 | Film No.: 23993408
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A